Navigation Links
A Call To Open Up The Channel Of Goodwill To Rescue The Dying Hearts

The plight of poor children with congenital heart diseases (CHD) here moved NRIs into donating// $200,000 at a fund-raiser dinner held in the US by a non-profit organization. About 40-50 NRIs have offered to sponsor a child each. Some of them are keen to sponsor a child or two every year

According to medical reports, every year, nearly 200,000 children are born in India with CHD. Only six to eight percent children affected with CHD receive medical treatment. Eighty percent of them die without timely treatment, as their families cannot afford the costs.

The cost of operating on a child with CHD is between Rs.50, 000 and Rs.300, 000 and depending on the nature of the disease, the number of related deaths keeps increasing day by day due to a lack of medical facilities, money and awareness.

Lack of proper nutrition during pregnancy, infections during pregnancy, late pregnancies, diabetes and genetic problems are some of the causes for children being born with CHD. All forms of CHD can be treated if only the affected children undergo surgery and medication in time

As responsible citizens, it is left to our capability to ensure that all the suffering children gain access to modern tertiary care which would not happen until a vigorous awareness programmes are conducted through out the country.

Source: IANS
'"/>




Page: 1

Related medicine news :

1. PharmaVentures Exploits Fastest Growing Media Channel to Launch First Pharmaceutical Business Television Show
2. New Way to Open Cellular Ion Channels, Implications for Drug Design
3. Altered Sodium Channel Function Linked to Heart Failure
4. How Ion Channels are Organized to Control Nerve Cell Communication?
5. Brain Networks Strengthened by Closing Ion Channels
6. Gujarat quake-Rescue teams give up hope of finding more survivors
7. RNA Nanotechnology To Rescue Cancer Patients In Future
8. Lung Cancer: Nutritional Intervention Comes To The Rescue
9. Hospital To The Rescue Of Disabled Children
10. Liver Transplants to the Rescue of Dreaded MSUD disease
11. Electronic Device to the Rescue of Women Using Contraceptive Pill
Post Your Comments:
Breaking Medicine Technology:National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards 2Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3Baxa Corporation Releases IntelliFlowRx 28TM 29 Upgrades 49198 1Baxa Corporation Releases IntelliFlowRx 28TM 29 Upgrades 49198 2Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 1Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 2Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 3Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 4Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 5Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 6Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 7Stroke Damage Is Less in Rats Given Opioids 49194 1